Results 221 to 230 of about 7,001,644 (259)
Some of the next articles are maybe not open access.
Measurement of disease progression in Alzheimer's disease
Neurobiology of Aging, 1988Riege and Metter's comprehensive review deals with many issues pertaining to Alzheimer's disease research. We agree with the authors that early diagnosis and evaluation of disease progression represent key points that must be addressed in an integrated manner. Brain imaging holds great promise for the resolution of both issues.
R P, Friedland, B, Horwitz, E, Koss
openaire +2 more sources
Gastroesophageal reflux disease is a progressive disease
Digestive and Liver Disease, 2007It is controversial whether gastrooesophageal reflux disease represents a spectrum disease from a nonerosive to a complicated one, or whether it is a categorial disease, i.e. it can be divided into three categories, such as nonerosive gastrooesophageal reflux disease, erosive gastrooesophageal reflux disease and Barrett's esophagus (BE) with little or ...
F. Pace, S. Pallotta, N. Vakil
openaire +3 more sources
Progress in Parkinson's Disease
New England Journal of Medicine, 1984Over the past few years important advances have taken place in the study of Parkinson's disease.
openaire +2 more sources
Progressive Shrinkage of Involved Arteries in Parallel with Disease Progression in Moyamoya Disease
World Neurosurgery, 2019Recent three-dimensional constructive interference in steady state (3D-CISS) studies have shown that the involved arteries decrease not only their own luminal caliber but also outer diameter in moyamoya disease (MMD). This study was aimed to clarify how the outer diameter of the involved arteries serially change during disease progression in MMD using ...
Shusuke Yamamoto +5 more
openaire +2 more sources
Statins and progressive renal disease
Medicinal Research Reviews, 2001AbstractThanks to the administration of hypocholesterolemic drugs, important advances have been made in the treatment of patients with progressive renal disease. In vitro and in vivo findings demonstrate that statins, the inhibitors of HMG‐CoA reductase, can provide protection against kidney diseases characterized by inflammation and/or enhanced ...
BUEMI, Michele +8 more
openaire +3 more sources
Factors for progression of periodontal diseases
Journal of Oral Pathology & Medicine, 1998Progression factors for periodontal diseases have been suggested by in vitro study of peripheral blood and gingival cells; however, those factors are not established in vivo. This investigation assessed biopsies of three groups of gingival tissues: those adjacent to a 1) 3 mm (normal), 2) 4‐6 mm, and 3) <6 mm gingival sulcus, to determine changes in
S D, Ellis +3 more
openaire +2 more sources
The progression of Parkinson disease
Neurology, 2007Recent neuropathologic studies suggest that Parkinson disease (PD) does not begin in the substantia nigra compacta (SNc) but only involves this region later in the course of the disease. It is proposed that once the SNc is affected by the original pathobiological process (for example, protein aggregation), additional processes more specific to ...
openaire +2 more sources
Characteristics of progressive renal disease
Clinica Chimica Acta, 2000Virtually all renal diseases progress to terminal renal failure relatively independently of the initial disease. Arresting the rate of the deterioration of kidney failure has a great impact on reducing the number of patients reaching the stage of expensive renal replacement therapy.
M, Ots, U, Pechter, A, Tamm
openaire +2 more sources
Pharmacoepigenomics in Neurodegenerative Diseases
Medical Epigenetics, 2021Nicoletta Nuzziello, Maria Liguori
exaly

